Effect of Jiangzhihuaxian capsule on hepatic fibrosis of chronic type B hepatitis
Zhao Aimi
Abstract
Zhao Aimi
Abstract
Objective To elucidate the effect of Jiangzhihuaxian capsule on hepatic fibrosis of chronic type B hepatitis. Methods 185 patients with chronic type B hepatitis of hepatic fibrosis were randomly divided into two groups. 91 cases in control group were treated by routine hepatinica. 94 patients in treatment group were treated by Jiangzhihuaxian, 5 pills, thrice a day plus routine hepatinica. The therapeutic course was 30 days in two groups. All patients were treated in three courses. Status of B-ultrasonography, liver function and indexes of hepatic fibrosis were observed before and after treatment. Results Improvement of liver reverberation and size of B-ultrasonography, liver function and indexes of hepatic fibrosis in treatment group were superior to those in control group (P0.05). The total effective rate in treatment group (93.62%) was higher than that in control group (80.22%, P0.05). Conclusion Jiangzhihuaxian capsule can obviously improve liver function and indexes of hepatic fibrosis. It has definite effect on hepatic fibrosis of chronic type B hepatitis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To elucidate the effect of Jiangzhihuaxian capsule on hepatic fibrosis of chronic type B hepatitis. Methods 185 patients with chronic type B hepatitis of hepatic fibrosis were randomly divided into two groups. 91 cases in control group were treated by routine hepatinica. 94 patients in treatment group were treated by Jiangzhihuaxian, 5 pills, thrice a day plus routine hepatinica. The therapeutic course was 30 days in two groups. All patients were treated in three courses. Status of B-ultrasonography, liver function and indexes of hepatic fibrosis were observed before and after treatment. Results Improvement of liver reverberation and size of B-ultrasonography, liver function and indexes of hepatic fibrosis in treatment group were superior to those in control group (P0.05). The total effective rate in treatment group (93.62%) was higher than that in control group (80.22%, P0.05). Conclusion Jiangzhihuaxian capsule can obviously improve liver function and indexes of hepatic fibrosis. It has definite effect on hepatic fibrosis of chronic type B hepatitis.
Key concepts: Medicine, Hepatic fibrosis, Capsule, Gastroenterology, Internal medicine, Fibrosis, Liver function, Chronic hepatitis